Shandong Realcan Pharmaceutical Co Ltd (002589) — Financial Flexibility Index
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥6.75 Million (operating CF CN¥-15.60 Million minus capex CN¥22.35 Million) represents 0% of total liabilities (CN¥9.87 Billion). Also explore net asset growth rate of Shandong Realcan Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Realcan Pharmaceutical Co Ltd Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Shandong Realcan Pharmaceutical Co Ltd across 17 annual periods. Check 002589 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shandong Realcan Pharmaceutical Co Ltd (2008–2024)
Year-by-year free cash flow to debt coverage for Shandong Realcan Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Shandong Realcan Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | CN¥271.97 Million | CN¥160.44 Million | CN¥10.32 Billion | ▼ -23.4% |
| 2023 | 0.03x | CN¥380.85 Million | CN¥82.47 Million | CN¥11.07 Billion | ▼ -37.7% |
| 2022 | 0.06x | CN¥694.04 Million | CN¥523.07 Million | CN¥12.58 Billion | ▲ +1.9% |
| 2021 | 0.05x | CN¥904.04 Million | CN¥442.95 Million | CN¥16.70 Billion | ▲ +27.3% |
| 2020 | 0.04x | CN¥920.35 Million | CN¥414.96 Million | CN¥21.65 Billion | ▼ -68.8% |
| 2019 | 0.14x | CN¥3.03 Billion | CN¥2.09 Billion | CN¥22.21 Billion | ▲ +697.0% |
| 2018 | 0.02x | CN¥402.66 Million | CN¥-201.66 Million | CN¥23.53 Billion | ▲ +114.5% |
| 2017 | -0.12x | CN¥-2.04 Billion | CN¥-2.42 Billion | CN¥17.31 Billion | ▲ +33.4% |
| 2016 | -0.18x | CN¥-1.44 Billion | CN¥-1.76 Billion | CN¥8.15 Billion | ▼ -170.4% |
| 2015 | -0.07x | CN¥-356.80 Million | CN¥-466.26 Million | CN¥5.46 Billion | ▼ -1383.3% |
| 2014 | 0.01x | CN¥19.63 Million | CN¥-163.62 Million | CN¥3.85 Billion | ▲ +111.8% |
| 2013 | -0.04x | CN¥-121.36 Million | CN¥-274.46 Million | CN¥2.80 Billion | ▼ -63.7% |
| 2012 | -0.03x | CN¥-58.27 Million | CN¥-170.52 Million | CN¥2.20 Billion | ▲ +91.7% |
| 2011 | -0.32x | CN¥-446.44 Million | CN¥-475.03 Million | CN¥1.40 Billion | ▼ -448.4% |
| 2010 | 0.09x | CN¥108.28 Million | CN¥70.56 Million | CN¥1.18 Billion | ▼ -8.6% |
| 2009 | 0.10x | CN¥80.62 Million | CN¥61.38 Million | CN¥805.78 Million | ▲ +419.2% |
| 2008 | -0.03x | CN¥-18.92 Million | CN¥-49.88 Million | CN¥603.64 Million | — |